Riskpilot← Back to searchSign inGet full accessTimra Medical AB
ABActiveOrg 5591688774Sankt Eriksgatan 96General medical practice activities · NACE 8621Est. 20180 employees
Revenue 2024
SEK 2,3M
+18% vs 2023
EBITDA margin
19.8%
+5% vs 2023
Equity ratio
18.0%
Financial strength
Net profit 2024
SEK 227K
+22% vs 2023
| Revenue | SEK 2,3M | +18% |
| EBITDA | SEK 461K | +5% |
| Net profit | SEK 227K | +22% |
| Total assets | SEK 2,9M | +0% |
| Equity | SEK 525K | +77% |
| Employees | 0 | — |
Legal name
Timra Medical AB
Org number
5591688774
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 augusti 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva läkarkonsultation inom hälso- och sjukvård, mottagningsverksamhet (både akut och planerad vård) inom privata och offentliga aktörer och därmed förenlig verksamhet. Bolaget skall även bedriva läkarkonsultation inom estetiska injektioner och trådlyft samt därmed förenlig verksamhet.
Address
Sankt Eriksgatan 96
Email
rosninva@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 453 | 2 327 | 1 778 | 1 972 | 2 322 |
| Staff expenses | — | — | — | — | −714 |
| EBITDA | 10 | 663 | 453 | 437 | 461 |
| Depreciation & amort. | −0 | −0 | −78 | −167 | −173 |
| EBIT | 10 | 663 | 375 | 270 | 287 |
| Net financials | — | −1 | −83 | −22 | 6 |
| Profit before tax | 10 | 663 | 291 | 247 | 294 |
| Tax | −3 | −139 | −64 | −61 | −66 |
| Net profit | 7 | 524 | 227 | 186 | 227 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 225 | 1 285 | 2 694 | 2 920 | 2 919 |
| Equity | 60 | 584 | 311 | 297 | 525 |
| Long-term debt | 0 | 0 | 1 610 | 2 150 | 2 150 |
| Short-term debt | 164 | 701 | 773 | 473 | 244 |
| Total debt | 164 | 701 | 2 383 | 2 623 | 2 394 |
EBITDA margin
19.8%
This company
15.8%
Market median
+25% vs market
20202024
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20202024
Return on equity
43.4%
This company
18.4%
Market median
+136% vs market
20202024
Net profit margin
9.8%
This company
8.1%
Market median
+21% vs market
20202024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
4.56×
This company
0.62×
Market median
-635% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Timra Medical AB 
Labdoc Sweden ABBoard members of Timra Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Romil Poli | Deputy Board Member | 0 companies |
| Ros-Ninva Daniela Verde Poli | Board of Directors | 0 companies |